HIGHLIGHTS
- who: Hasan Vatandaslar from the Institute of Molecular Health Sciences, Department of Biology, ETH Zurich, Zurich, Switzerland have published the paper: A Systematic Study on the Optimal Nucleotide Analogue Concentration and Rate Limiting Nucleotide of the SARS-CoV-2 RNA-Dependent RNA Polymerase, in the Journal: (JOURNAL) of 23/07/2022
- what: The authors show that SARS-CoV-2 RdRp inhibition efficiency of remdesivir and cordycepin two common adenosine analogs is influenced by endogenous adenosine level and that the current clinically approved concentrations for COVID-19 treatment are suboptimal for effective RdRp inhibition. As the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.